| Product Name | NebuSelect™ Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1, His-tag |
|---|---|
| Catalog Number | NBL-241754 |
| Alias/Synonyms | CLEC12A/MICL/CLL-1 |
| Appearance | see COA |
| Molecule Weight | His65-Ala265 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q5QGZ9-2 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241754-100ug | 100ug | Inquire | Inquire | |
| NBL-241754-1mg | 1mg | Inquire | Inquire | |
| NBL-241754-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1, His-tag
Catalog#:
NBL-241754
Description:
NebuSelect™ Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1, His-tag(Cat#NBL-241754) is expressed in HEK293 with His tag at the N-Terminus.It contains His65-Ala265.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 24.6 kDa. Due to glycosylation, the protein migrates to 35-55 kDa based on Bis-Tris PAGE result.
Target Name:
CLEC12A/MICL/CLL-1
Target Information:
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.
Amino Acid Sequence:
His65-Ala265
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.